This guidance has been updated and replaced by NICE diagnostics guidance 40.
NICE has assessed 3 viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems), to help the NHS decide whether to use these products
This guideline covers organisational and managerial approaches to safe nurse staffing of inpatient wards for people aged 18 and over in acute hospitals. It aims to ensure that patients receive the nursing care they need, regardless of the ward to which they are allocated, the time of the day, or the day of the week.
Evidence-based recommendations on the geko device for reducing the risk of venous thromboembolism
April 2020: This guidance has been withdrawn while the MHRA conducts an investigation into the MAGEC system. The MHRA issued a Medical Device Alert MDA/2020/011 for all MAGEC systems. This is in response to the manufacturer’s latest Field Safety Notice and previous field safety notices for problems that may require early removal of devices and lead to inadequate treatment. The MHRA is not recommending prophylactic removal of devices but the supply of all MAGEC systems is suspended in the UK while the MHRA investigation is ongoing. The MHRA has set out the following actions: Do not implant MAGEC rods in the UK until further notice. Identify all patients implanted with a MAGEC System and ensure systems are in place to follow up these patients.
Evidence-based recommendations on NIOX MINO, NIOX VERO and NObreath for measuring the amount of exhaled nitric oxide (FeNO) in the breath to help diagnose
This guideline covers good practice for managing medicines in care homes. It aims to promote the safe and effective use of medicines in care homes by advising on processes for prescribing, handling and administering medicines. It also recommends how care and services relating to medicines should be provided to people living in care homes.
Evidence-based recommendations on faecal calprotectin tests for distinguishing between inflammatory bowel diseases (such as Crohn’s disease and ulcerative
This guidance has been updated and replaced by NICE diagnostics guidance 34.
Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic
Evidence-based recommendations on the RD-100i OSNA system and Metasin test for detecting sentinel lymph node metastases in people having breast cancer surgery
In March 2019, NICE reviewed this guidance and recommended it should be withdrawn because Vision Amniotic Leak Detector is no longer available. NICE has produced a medtech innovation briefing on AmnioSense for unexplained vaginal wetness in pregnancy. For a copy of the review decision, please contact nice@nice.org.uk.
Evidence-based recommendations on the WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension
Evidence-based recommendations on SeHCAT (tauroselcholic [75selenium] acid) for diagnosing bile acid malabsorption in people with IBS-D or Crohn’s disease
Evidence-based recommendations on 3 electroencephalography (EEG)-based depth of anaesthesia monitors for assessing a patient’s response to anaesthetic drugs
Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver
Evidence-based recommendations on the Mega Soft Patient Return Electrode for use during monopolar electrosurgery
This guidance has been updated and replaced by NICE diagnostics guidance 32.
Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.
Evidence-based recommendations on the EOS 2D/3D imaging system for producing 2D and 3D images of the skeleton
In March 2018, NICE reviewed this guidance and recommended it should be withdrawn as it has been updated and replaced by the NICE guideline on hypothermia: prevention and management in adults having surgery. For a copy of the review decision please contact nice@nice.org.uk.
Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing
Evidence-based recommendations on Ambulight PDT for the treatment of non-melanoma skin cancer
In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.
This medical technologies guidance has been replaced by the recommendation on cardiac output monitoring in the NICE guideline on perioperative care in adults.
Evidence-based recommendations on SeQuent Please balloon catheter for in-stent coronary restenosis
In development [GID-DG10040] Expected publication date: 17 November 2021
Proposed [GID-HST10020] Expected publication date: TBC
Proposed [GID-HST10019] Expected publication date: TBC
In development [GID-DG10036] Expected publication date: TBC
In development [GID-DG10039] Expected publication date: 17 November 2021
In development [GID-SGWAVE0701] Expected publication date: TBC
In development [GID-SGWAVE0700] Expected publication date: TBC
In development [GID-SGWAVE0702] Expected publication date: TBC
Proposed [GID-HST10034] Expected publication date: TBC
In development [GID-NG10167] Expected publication date: TBC
In development [GID-NG10168] Expected publication date: TBC
In development [GID-MT544] Expected publication date: 15 September 2020
In development [GID-MT538] Expected publication date: TBC
In development [GID-SGWAVE0761] Expected publication date: TBC
In development [GID-SGWAVE0762] Expected publication date: TBC
In development [GID-HST10010] Expected publication date: TBC
In development [GID-MT510] Expected publication date: TBC
In development [GID-MT517] Expected publication date: TBC
In development [GID-HST10017] Expected publication date: TBC
In development [GID-NG10166] Expected publication date: TBC
In development [GID-MT130] Expected publication date: TBC
In development [GID-DT9] Expected publication date: TBC
In development [GID-MT163] Expected publication date: TBC
In development [GID-DT14] Expected publication date: TBC